Drug metabolism in carcinogenesis and cancer chemotherapy
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 51 (2) , 275-289
- https://doi.org/10.1016/0163-7258(91)90083-x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The Role of Glutathione and Glutathione Transferases in Chemical CardnogenesiCritical Reviews in Biochemistry and Molecular Biology, 1990
- The effect of cimetidine on cyclophosphamide metabolism in rabbitsCancer Chemotherapy and Pharmacology, 1990
- The role of reductive and oxidative metabolism in the toxicity of mitoxantrone, adriamycin and menadione in human liver derived Hep G2 hepatoma cellsBritish Journal of Cancer, 1989
- v-ras genes from harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesisCell, 1986
- Mitoxantrone affects topoisomerase activities in human breast cancer cellsBiochemical and Biophysical Research Communications, 1986
- Metabolic oxidation phenotypes as markers for susceptibility to lung cancerNature, 1984
- Oxidative destruction of DNA by the adriamycin-iron complexBiochemistry, 1984
- ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCERThe Lancet, 1982
- Lung-toxic furanoterpenoids produced by sweet potatoes (Ipomoea batatas) following microbial infectionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1974
- Isolation and characterization of 4-ipomeanol, a lung-toxic furanoterpenoid produced by sweet potatoes (Ipomoea batatas)Journal of Agricultural and Food Chemistry, 1972